{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:06:34Z","timestamp":1790676394649,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier","isbn-type":[{"value":"9780128047361","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/bs.aivir.2016.08.003","type":"book-chapter","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T15:10:52Z","timestamp":1473433852000},"page":"245-286","source":"Crossref","is-referenced-by-count":133,"title":["Molecular Basis of Coronavirus Virulence and Vaccine Development"],"prefix":"10.1016","author":[{"given":"L.","family":"Enjuanes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Casta\u00f1o-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gutierrez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Canton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.aivir.2016.08.003_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coviro.2014.06.002","article-title":"Antiviral drugs specific for coronaviruses in preclinical development","volume":"8","author":"Adedeji","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0010","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/JVI.03427-14","article-title":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease","volume":"89","author":"Agrawal","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0015","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1073\/pnas.97.10.5516","article-title":"Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome","volume":"97","author":"Almazan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00650-13","article-title":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate","volume":"4","author":"Almazan","year":"2013","journal-title":"MBio"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0025","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/v6072735","article-title":"Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases","volume":"6","author":"Altenburg","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0030","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1128\/JVI.73.9.7853-7859.1999","article-title":"Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer","volume":"73","author":"An","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0035","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00524-13","article-title":"Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles","volume":"4","author":"Angelini","year":"2013","journal-title":"MBio"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2217\/fvl.11.33","article-title":"Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy","volume":"6","author":"Barnard","year":"2011","journal-title":"Futur. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0045","doi-asserted-by":"crossref","first-page":"15189","DOI":"10.1128\/JVI.79.24.15189-15198.2005","article-title":"The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity","volume":"79","author":"Barretto","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0050","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.virol.2005.11.044","article-title":"Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated","volume":"347","author":"Butler","year":"2006","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0060","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1128\/JVI.00009-13","article-title":"Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures","volume":"87","author":"Chan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0065","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0075","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1128\/JVI.02747-06","article-title":"Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0080","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13238-014-0026-3","article-title":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex","volume":"5","author":"Chen","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0090","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1128\/JVI.79.12.7819-7826.2005","article-title":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis","volume":"79","author":"Cheung","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2014.02.018","article-title":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response","volume":"454\u2013455","author":"Chu","year":"2014","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0100","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/infdis\/jiv380","article-title":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways","volume":"213","author":"Chu","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0105","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/JVI.02406-09","article-title":"Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases","volume":"84","author":"Clementz","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0110","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1128\/JVI.03764-13","article-title":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection","volume":"88","author":"Cockrell","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0115","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0120","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1099\/vir.0.060640-0","article-title":"Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus","volume":"95","author":"Coleman","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0125","first-page":"1392","article-title":"In vitro detection of apoptosis in monocytes\/macrophages infected with human coronavirus","volume":"9","author":"Collins","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0130","doi-asserted-by":"crossref","first-page":"11297","DOI":"10.1128\/JVI.01498-14","article-title":"Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat","volume":"88","author":"Corman","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/biot.201500236","article-title":"Selecting the optimal Tet-On system for doxycycline-inducible gene expression in transiently transfected and stably transduced mammalian cells","volume":"11","author":"Das","year":"2016","journal-title":"Biotechnol. J."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.virol.2009.09.023","article-title":"A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo","volume":"395","author":"Day","year":"2009","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0145","series-title":"Virus Taxonomy","first-page":"774","article-title":"Family coronaviridae","author":"de Groot","year":"2012"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0150","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/JVI.01467-06","article-title":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo","volume":"81","author":"DeDiego","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0155","doi-asserted-by":"crossref","first-page":"e1002315","DOI":"10.1371\/journal.ppat.1002315","article-title":"Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis","volume":"7","author":"DeDiego","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virusres.2014.07.024","article-title":"Coronavirus virulence genes with main focus on SARS-CoV envelope gene","volume":"194","author":"DeDiego","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/JVI.02576-13","article-title":"Inhibition of NF-kappaB mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival","volume":"88","author":"DeDiego","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0170","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1128\/JVI.02699-12","article-title":"The acetyl-esterase activity of the hemagglutinin-esterase protein of human coronavirus OC43 strongly enhances the production of infectious virus","volume":"87","author":"Desforges","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1743-422X-3-106","article-title":"Human coronavirus 229E encodes a single ORF4 protein between the spike and the envelope genes","volume":"3","author":"Dijkman","year":"2006","journal-title":"Virol. J."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0180","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1128\/JVI.03368-12","article-title":"Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism","volume":"87","author":"Dijkman","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0185","doi-asserted-by":"crossref","first-page":"11948","DOI":"10.1128\/JVI.01804-08","article-title":"Systematic assembly of a full-length infectious clone of human coronavirus NL63","volume":"82","author":"Donaldson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/cid\/ciu812","article-title":"An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014","volume":"60","author":"Drosten","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0195","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/14712598.2015.1092518","article-title":"Middle East respiratory syndrome: current status and future prospects for vaccine development","volume":"15","author":"Du","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0200","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0205","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of receptor-binding domain in S protein of the novel human coronavirus MERS-CoV as an essential target for vaccine development","volume":"17","author":"Du","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0210","doi-asserted-by":"crossref","first-page":"e1000896","DOI":"10.1371\/journal.ppat.1000896","article-title":"Infidelity of SARS-CoV nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing","volume":"6","author":"Eckerle","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virusres.2007.01.021","article-title":"Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease","volume":"133","author":"Enjuanes","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0220","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1128\/JVI.02082-08","article-title":"Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1\u2033-phosphatase, a viral function conserved in the alpha-like supergroup","volume":"82","author":"Eriksson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.virol.2014.01.002","article-title":"Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein","volume":"452\u2013453","author":"Escriou","year":"2014","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0230","doi-asserted-by":"crossref","first-page":"e1004250","DOI":"10.1371\/journal.ppat.1004250","article-title":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset","volume":"10","author":"Falzarano","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.virol.2009.09.026","article-title":"A human coronavirus OC43 variant harboring persistence-associated mutations in the S glycoprotein differentially induces the unfolded protein response in human neurons as compared to wild-type virus","volume":"395","author":"Favreau","year":"2009","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0240","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1128\/JVI.00087-13","article-title":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein","volume":"87","author":"Fett","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0245","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.02220-08","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling","volume":"83","author":"Frieman","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0250","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.05957-11","article-title":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease","volume":"86","author":"Frieman","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0255","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/nm.2972","article-title":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease","volume":"18","author":"Graham","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coviro.2015.06.009","article-title":"Animal models for SARS and MERS coronaviruses","volume":"13","author":"Gretebeck","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0265","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0270","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/imm.12462","article-title":"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus","volume":"145","author":"Guo","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0275","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1128\/JVI.00661-15","article-title":"Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits","volume":"89","author":"Haagmans","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0290","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/JVI.02980-14","article-title":"Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology","volume":"89","author":"Honda-Okubo","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0295","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12250-010-3096-2","article-title":"Immunogenicity of the spike glycoprotein of bat SARS-like coronavirus","volume":"25","author":"Hou","year":"2010","journal-title":"Virol. Sin."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0300","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1128\/JVI.00854-15","article-title":"Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme","volume":"89","author":"Huang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0305","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1128\/JVI.00983-14","article-title":"Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB\/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine","volume":"88","author":"Iwata-Yoshikawa","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0310","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0042-6822(03)00323-4","article-title":"Vacuolating encephalitis in mice infected by human coronavirus OC43","volume":"315","author":"Jacomy","year":"2003","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0315","first-page":"31","article-title":"SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement","volume":"18","author":"Jaume","year":"2012","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0320","doi-asserted-by":"crossref","first-page":"234ra259","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0325","doi-asserted-by":"crossref","first-page":"e1004320","DOI":"10.1371\/journal.ppat.1004320","article-title":"The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein Is a determinant of viral pathogenesis","volume":"10","author":"Jimenez-Guarde\u00f1o","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0330","doi-asserted-by":"crossref","first-page":"e1005215","DOI":"10.1371\/journal.ppat.1005215","article-title":"Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine","volume":"11","author":"Jimenez-Guardeno","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0335","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1128\/AAC.01509-08","article-title":"Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice","volume":"53","author":"Keyaerts","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.antiviral.2013.11.004","article-title":"Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors","volume":"101","author":"Kilianski","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0345","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0350","doi-asserted-by":"crossref","first-page":"e00611","DOI":"10.1128\/mBio.00611-12","article-title":"Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential","volume":"4","author":"Kindler","year":"2013","journal-title":"MBio"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0355","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"Kirkpatrick","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0360","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1099\/vir.0.031856-0","article-title":"The ADP-ribose-1\u2033-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses","volume":"92","author":"Kuri","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0365","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1128\/JVI.00304-08","article-title":"A live attenuated SARS coronavirus is immunogenic and efficacious in golden Syrian hamsters","volume":"82","author":"Lamirande","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0370","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ebiom.2015.08.031","article-title":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge","volume":"2","author":"Lan","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0375","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1073\/pnas.0408589102","article-title":"Development of a transgenic mouse model susceptible to human coronavirus 229E","volume":"102","author":"Lassnig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0380","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","article-title":"Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells","volume":"106","author":"Law","year":"2005","journal-title":"Blood"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0385","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2172-10-35","article-title":"Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells","volume":"10","author":"Law","year":"2009","journal-title":"BMC Immunol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0390","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/vim.2012.0076","article-title":"Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates","volume":"26","author":"Li","year":"2013","journal-title":"Viral Immunol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0400","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/infdis\/jiv499","article-title":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4","volume":"213","author":"Li","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0405","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","article-title":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0410","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1128\/JVI.01352-15","article-title":"Middle East Respiratory Syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin","volume":"89","author":"Lokugamage","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0415","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2014.02.004","article-title":"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0420","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1016\/j.vaccine.2014.08.086","article-title":"Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments\u2014the importance of immunofocusing in subunit vaccine design","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0425","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1093\/nar\/gni062","article-title":"Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter","volume":"33","author":"Markusic","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0430","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1099\/vir.0.062059-0","article-title":"The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling","volume":"95","author":"Matthews","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0435","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ejh.12744","article-title":"Fatal outcome of human coronavirus NL63 infection despite successful viral elimination by IFN-alpha in a patient with newly diagnosed ALL","volume":"97","author":"Mayer","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0440","first-page":"4251","article-title":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2\u2032-o-methyltransferase activity","volume":"88","author":"Menachery","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0445","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1128\/JVI.00269-12","article-title":"A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes","volume":"86","author":"Mesel-Lemoine","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0450","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2013.11.040","article-title":"MERS-CoV papain-like protease has deISGylating and deubiquitinating activities","volume":"450\u2013451","author":"Mielech","year":"2014","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0455","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0508200103","article-title":"Discovery of an RNA virus 3\u2032\u21925\u2032 exoribonuclease that is critically involved in coronavirus RNA synthesis","volume":"103","author":"Minskaia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0460","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1128\/JVI.01277-13","article-title":"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies","volume":"87","author":"Mou","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0465","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-7-6","article-title":"Human coronavirus NL63 open reading frame 3 encodes a virion-incorporated N-glycosylated membrane protein","volume":"7","author":"Muller","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0470","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/JCM.01368-15","article-title":"Infectious Middle East respiratory syndrome coronavirus excretion and serotype variability based on live virus isolates from patients in Saudi Arabia","volume":"53","author":"Muth","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0475","doi-asserted-by":"crossref","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0480","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virusres.2014.11.019","article-title":"Coronavirus nonstructural protein 1: common and distinct functions in the regulation of host and viral gene expression","volume":"202","author":"Narayanan","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0485","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virol.2010.01.004","article-title":"Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease","volume":"399","author":"Netland","year":"2010","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0490","doi-asserted-by":"crossref","first-page":"e1004077","DOI":"10.1371\/journal.ppat.1004077","article-title":"Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis","volume":"10","author":"Nieto-Torres","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0495","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.virol.2015.08.010","article-title":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome","volume":"485","author":"Nieto-Torres","year":"2015","journal-title":"Virology"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0500","author":"Paddock"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0505","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1586\/14760584.2015.1036033","article-title":"Middle East respiratory syndrome: obstacles and prospects for vaccine development","volume":"14","author":"Papaneri","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0510","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0515","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1099\/0022-1317-60-2-307","article-title":"Replication of human respiratory coronavirus strain 229E in human macrophages","volume":"60","author":"Patterson","year":"1982","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0520","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1128\/JVI.03445-14","article-title":"Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection","volume":"89","author":"Peck","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0525","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1086\/377612","article-title":"Coronavirus 229E-related pneumonia in immunocompromised patients","volume":"37","author":"Pene","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0530","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1128\/JVI.79.20.12721-12731.2005","article-title":"ADP-ribose-1\u2033-monophosphatase: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture","volume":"79","author":"Putics","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0535","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/AAC.01598-05","article-title":"Inhibition of human coronavirus NL63 infection at early stages of the replication cycle","volume":"50","author":"Pyrc","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0540","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/187152607780090757","article-title":"Antiviral strategies against human coronaviruses","volume":"7","author":"Pyrc","year":"2007","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0545","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.0510851103","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme","volume":"103","author":"Ratia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0550","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1128\/JVI.03566-14","article-title":"Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates","volume":"89","author":"Regla-Nava","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0555","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1371\/journal.ppat.0030005","article-title":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice","volume":"3","author":"Roberts","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0560","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/vim.2010.0028","article-title":"Immunogenicity and protective efficacy in mice and hamsters of a beta-propiolactone inactivated whole virus SARS-CoV vaccine","volume":"23","author":"Roberts","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0565","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/JVI.02203-08","article-title":"Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2","volume":"83","author":"Roth-Cross","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0570","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.aac8608","article-title":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia","volume":"351","author":"Sabir","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0575","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/JVI.03607-14","article-title":"High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus","volume":"89","author":"Scheuplein","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0580","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.1311542110","article-title":"Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus","volume":"110","author":"Scobey","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0585","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1186\/1471-2164-15-1161","article-title":"Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates","volume":"15","author":"Selinger","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0590","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/JVI.01805-10","article-title":"Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus","volume":"85","author":"Sheahan","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0595","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1743-422X-9-215","article-title":"Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain","volume":"9","author":"Shim","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0600","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-3701-4-3","article-title":"Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1","volume":"4","author":"Siu","year":"2014","journal-title":"Cell Biosci."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0605","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1128\/JVI.03649-13","article-title":"Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in innate antiviral response","volume":"88","author":"Siu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0610","doi-asserted-by":"crossref","first-page":"e1003565","DOI":"10.1371\/journal.ppat.1003565","article-title":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics","volume":"9","author":"Smith","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0615","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-virology-100114-055218","article-title":"Continuous and discontinuous RNA synthesis in coronaviruses","volume":"2","author":"Sola","year":"2015","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0620","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"Song","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0625","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.1128\/JVI.78.16.8824-8834.2004","article-title":"Human respiratory coronavirus OC43: genetic stability and neuroinvasion","volume":"78","author":"St-Jean","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0630","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/JVI.80.7.3670-3674.2006","article-title":"Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone","volume":"80","author":"St-Jean","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0635","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1586\/14760584.2015.1095096","article-title":"Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes","volume":"14","author":"Stobart","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0640","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0645","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","article-title":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants","volume":"79","author":"Sui","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0650","doi-asserted-by":"crossref","first-page":"13769","DOI":"10.1128\/JVI.02232-14","article-title":"Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness","volume":"88","author":"Sui","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0655","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01850","article-title":"Integration of interferon-alpha\/beta signalling to p53 responses in tumour suppression and antiviral defence","volume":"424","author":"Takaoka","year":"2003","journal-title":"Nature"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0660","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0665","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/21645515.2015.1021527","article-title":"Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus","volume":"11","author":"Tang","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0670","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/JVI.02009-15","article-title":"Characterization and demonstration of the value of a lethal mouse model of Middle East Respiratory Syndrome coronavirus infection and disease","volume":"90","author":"Tao","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0675","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0680","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1099\/0022-1317-82-6-1273","article-title":"Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus","volume":"82","author":"Thiel","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0685","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0690","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.4049\/jimmunol.174.12.7977","article-title":"Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection","volume":"174","author":"Tseng","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0695","doi-asserted-by":"crossref","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0700","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/135965350701200S01.1","article-title":"Human coronaviruses: what do they cause?","volume":"12","author":"van der Hoek","year":"2007","journal-title":"Antivir. Ther."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0705","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"van der Hoek","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0710","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1371\/journal.pmed.0020240","article-title":"Croup is associated with the novel coronavirus NL63","volume":"2","author":"van der Hoek","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0715","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2015.07.005","article-title":"Animal models of Middle East respiratory syndrome coronavirus infection","volume":"122","author":"van Doremalen","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0720","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1128\/JVI.00676-14","article-title":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4","volume":"88","author":"van Doremalen","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0725","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MCP.0b013e3282f4a99f","article-title":"Viral infections in patients with chronic obstructive pulmonary disease","volume":"14","author":"Varkey","year":"2008","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0730","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East Respiratory Syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0735","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/infdis\/jit393","article-title":"Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations","volume":"208","author":"Walsh","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0740","doi-asserted-by":"crossref","first-page":"e37019","DOI":"10.1371\/journal.pone.0037019","article-title":"The adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primates","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0745","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0750","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0755","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0760","doi-asserted-by":"crossref","first-page":"9313","DOI":"10.1128\/JVI.01237-15","article-title":"A coronavirus E protein is present in two distinct pools with different effects on assembly and the secretory pathway","volume":"89","author":"Westerbeck","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0765","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.79.2.884-895.2005","article-title":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia","volume":"79","author":"Woo","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0770","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1086\/497151","article-title":"Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia","volume":"192","author":"Woo","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0775","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/v6093683","article-title":"IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms","volume":"6","author":"Wrensch","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0780","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clim.2006.05.002","article-title":"Long-lived effector\/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients","volume":"120","author":"Yang","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0785","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s13238-013-3096-8","article-title":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists","volume":"4","author":"Yang","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0790","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1099\/vir.0.059014-0","article-title":"Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease","volume":"95","author":"Yang","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0795","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virusres.2004.09.004","article-title":"SARS-coronavirus replication in human peripheral monocytes\/macrophages","volume":"107","author":"Yilla","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0800","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1128\/JVI.00912-14","article-title":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies","volume":"88","author":"Ying","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0805","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.micinf.2014.11.008","article-title":"Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections","volume":"17","author":"Ying","year":"2015","journal-title":"Microbes Infect."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0810","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.1038\/ncomms9223","article-title":"Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody","volume":"6","author":"Ying","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0815","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/infdis\/jiv381","article-title":"Discovery of T-Cell infection and apoptosis by Middle East Respiratory Syndrome Coronavirus","volume":"213","author":"Ying","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0820","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1073\/pnas.1735582100","article-title":"Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus","volume":"100","author":"Yount","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0825","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1074\/jbc.M114.619890","article-title":"p53 degradation by a coronavirus papain-like protease suppresses type I interferon signaling","volume":"290","author":"Yuan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0830","first-page":"151","article-title":"Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS","volume":"7","author":"Zhang","year":"2005","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0835","doi-asserted-by":"crossref","first-page":"13114","DOI":"10.1073\/pnas.1306917110","article-title":"Homologous 2\u2032,5\u2032-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0840","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.2014.912134","article-title":"Current advancements and potential strategies in the development of MERS-CoV vaccines","volume":"13","author":"Zhang","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0845","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbamem.2013.07.025","article-title":"The ORF4a protein of human coronavirus 229E functions as a viroporin that regulates viral production","volume":"1838","author":"Zhang","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0850","doi-asserted-by":"crossref","first-page":"11383","DOI":"10.1128\/JVI.01986-15","article-title":"The ns12.9 accessory protein of human coronavirus OC43 Is a viroporin involved in virion morphogenesis and pathogenesis","volume":"89","author":"Zhang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0855","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0860","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.chom.2012.04.011","article-title":"Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology","volume":"11","author":"Zhao","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0865","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0870","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1073\/pnas.1320856111","article-title":"Interferon induction of IFITM proteins promotes infection by human coronavirus OC43","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0875","doi-asserted-by":"crossref","first-page":"e0145561","DOI":"10.1371\/journal.pone.0145561","article-title":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0880","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1128\/JVI.00446-15","article-title":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection","volume":"89","author":"Zhao","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0885","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/cr.2008.294","article-title":"PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production","volume":"18","author":"Zheng","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0890","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/v4060980","article-title":"Recent progress in studies of arterivirus- and coronavirus-host interactions","volume":"4","author":"Zhong","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0895","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12250-013-3292-y","article-title":"Identification of immunogenic determinants of the spike protein of SARS-like coronavirus","volume":"28","author":"Zhou","year":"2013","journal-title":"Virol. Sin."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0900","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/1471-2334-13-433","article-title":"First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood","volume":"13","author":"Zhou","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0905","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/infdis\/jit504","article-title":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis","volume":"209","author":"Zhou","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0910","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12985-015-0446-6","article-title":"Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis","volume":"12","author":"Zhou","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0915","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.0701000104","article-title":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0920","first-page":"57","article-title":"The coronavirus replicase","volume":"vol. 287","author":"Ziebuhr","year":"2005"},{"key":"10.1016\/bs.aivir.2016.08.003_bb0925","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1128\/JVI.79.21.13800-13805.2005","article-title":"Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells","volume":"79","author":"Ziegler","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0930","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/JVI.03496-12","article-title":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus","volume":"87","author":"Zielecki","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0935","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses\u2014drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0940","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1371\/journal.ppat.0030109","article-title":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines","volume":"3","author":"Zust","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/bs.aivir.2016.08.003_bb0945","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ni.1979","article-title":"Ribose 2\u2032-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5","volume":"12","author":"Zust","year":"2011","journal-title":"Nat. Immunol."}],"container-title":["Advances in Virus Research","Coronaviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065352716300422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065352716300422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T01:03:32Z","timestamp":1657242212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065352716300422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128047361"],"references-count":189,"URL":"https:\/\/doi.org\/10.1016\/bs.aivir.2016.08.003","relation":{},"ISSN":["0065-3527"],"issn-type":[{"value":"0065-3527","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}